Akebia Therapeutics Inc. (AKBA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akebia Therapeutics Inc.

    NASDAQ: AKBA · Real-Time Price · USD
    2.93
    -0.07 (-2.33%)
    At close: Sep 10, 2025, 3:59 PM
    2.93
    0.01%
    After-hours: Sep 10, 2025, 07:59 PM EDT

    Akebia Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -69.41M -51.92M -92.56M -282.84M
    Depreciation & Amortization
    		 37.5M 41.85M 37.7M 37.97M
    Stock-Based Compensation
    		 7.78M 9.32M 17.85M 22.73M
    Other Working Capital
    		 -13.96M -13.94M -34.42M -46.81M
    Other Non-Cash Items
    		 23.15M -1.9M -34.7M 41.01M
    Deferred Income Tax
    		 n/a n/a n/a 36.58M
    Change in Working Capital
    		 -39.68M -20.73M -1.44M -108.42M
    Operating Cash Flow
    		 -40.66M -23.38M -73.15M -252.97M
    Capital Expenditures
    		 -33K n/a -114K -59K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a 40M
    Other Investing Acitivies
    		 n/a n/a n/a 40M
    Investing Cash Flow
    		 -33K n/a -114K 39.94M
    Debt Repayment
    		 7.9M -32M -33M n/a
    Common Stock Repurchased
    		 -1.27M n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 385K 1K 40.07M 133.73M
    Financial Cash Flow
    		 49.66M -25.21M 14.6M 133.73M
    Net Cash Flow
    		 8.97M -48.59M -58.67M -79.29M
    Free Cash Flow
    		 -40.69M -23.38M -73.27M -253.02M

    Add to Watchlist